Myco-Minds Institute

A Psilocybin Session Facilitator Training for Licensed Professionals

What you'll learn

Understand the current state of research on psilocybin therapy, including its history, potential benefits, and limitations

Explore administration of psilocybin in therapy including their effects on the brain and mind

Gain a historical perspective on the use of psilocybin, including its traditional use in indigenous cultures and its emergence in the Western world

Analyze the therapeutic frameworks and approaches used in psilocybin facilitation, such as set and setting, integration, and preparation and aftercare.

Evaluate the ethical and legal considerations related to psilocybin facilitation, including the role of the facilitator, patient safety, and potential barriers

Analyze the existing research on the effectiveness of psilocybin-assisted therapy for treating mental health disorders.

Apply knowledge of the principles and practices of psilocybin assisted therapy to create treatment plans and protocols for clients.

Requirements

Must be 21 years or over

Must be currently licensed as a psychiatrist, psychologist, counselor, therapist, social worker, doctor, nurse, home health aid or other healthcare worker

The online component of this program is self-directed, and at your own pace, but you can reach out to our educators at any point you need assistance, as well as discuss and network with other students through sharing your writing assignments

Description

Welcome to Myco-Minds Institute! This comprehensive program  uses Myco-Method, an Oregon Health Authority-approved Psilocybin Facilitator Training Program curriculum to provide in-depth education to professionally licensed healthcare and mental healthcare workers seeking to become competent and responsible psilocybin facilitators.  The full Facilitator Training Program component of Myco-Minds Institute has received approval to provide the training required for licensure of facilitators in Oregon.  As psilocybin-assisted therapy gains recognition as a viable treatment for mental health conditions, the need for properly trained and qualified facilitators is increasing. Our program aims to provide a rigorous and well-rounded training that will equip licensed healthcare professionals with the necessary knowledge, skills, and ethical guidelines to facilitate psilocybin sessions safely and effectively.Myco-Minds Institute's Facilitator Training Program requires a total of 160 hours of instruction, which includes in-person training, online training, and practicum study.The online training component consists of 60 hours of instruction, which provides students with flexibility in their learning and allows them to progress through the material at their own pace.  It is anticipated it will take approximately 4-6 months to complete. The online training includes articles, essays, lectures, videos, poems, demonstrations, quizzes, and writing assignments, providing a comprehensive exploration of the material.  Further, although the online course is self-paced, participants still have the opportunity to connect with instructors and others in their learning cohort, through sharing their writing assignments and providing feedback to others as they move through the course.For those looking to complete the full Facilitator Training Program, additional requirements include an in-person residency and a practicum.  The in-person training component consists of 60-hours of immersive learning experience with other experienced facilitators and students. This portion of the training includes lectures, interactive discussions, and experiential learning opportunities, allowing students to develop their skills and knowledge in a collaborative and supportive environment.The practicum component consists of an additional 40 hours of supervised learning in practicum, which allows students to deepen their understanding of the material and apply their knowledge in practical ways. Students will have access to resources and support to facilitate their learning and ensure they are meeting the requirements of the program.Through this comprehensive and rigorous training program, students will develop the knowledge and skills necessary to become competent and compassionate psilocybin session facilitators.

Overview

Section 1: Introduction

Lecture 1 Myco-Minds Institute Introduction

Lecture 2 Meet the Instructors: Shasta

Lecture 3 Meet the Instructors: Karlene

Lecture 4 Meet the Instructors: Dodi

Lecture 5 Meet the Instructors: Campton

Lecture 6 Overview of Myco-Minds Institute

Lecture 7 Program Components

Lecture 8 Objectives and Learning Outcomes

Lecture 9 Ethical and Legal considerations

Section 2: Foundations of Psychedelic Therapy

Lecture 10 Introduction to psychedelic-assisted therapy

Lecture 11 History of psychedelic therapy and research

Lecture 12 Theoretical frameworks and models of psychedelic therapy

Section 3: Historical, Traditional, and Contemporary Practices and Applications

Lecture 13 Historical, Traditional Use and Contemporary Practices Video

Lecture 14 Current and Historical Use

Lecture 15 The Controlled Substances Act

Lecture 16 Overview of historical and present research

Section 4: Cultural Equity in Relation to Psilocybin Services

Lecture 17 Intro to Cultural Equity Video

Lecture 18 Cultural Equity in Psilocybin Services

Lecture 19 Racial Justice

Lecture 20 The Impact of Drug Policy

Lecture 21 History of Systemic Inequality

Lecture 22 Intergenerational trauma

Lecture 23 Responsible Referral and Support

Section 5: Safety, Ethics, Law and Responsibilities

Lecture 24 Intro to Safety, Ethics, the Law and Responsibility Video

Lecture 25 Prohibited Conduct

Lecture 26 Awareness of Facilitator Bias

Lecture 27 Intro to Measure 109 Video

Lecture 28 The Oregon Psilocybin Services Act

Lecture 29 Oregon’s Facilitator Code of Ethics

Lecture 30 Intro to Boundaries for Psilocybin Facilitators Video

Lecture 31 Ethical considerations relating to equity, privilege, bias and power

Lecture 32 Awareness of increased vulnerability

Lecture 33 Appropriate use of touch and client consent to physical contact

Lecture 34 Appropriate emotional and sexual boundaries

Lecture 35 Financial conflicts of interest

Lecture 36 Advertising Restrictions

Lecture 37 Intro to Scope of Practice for Psilocybin Facilitators Video

Lecture 38 Reasonable expectations regarding client outcomes

Lecture 39 Accurate record keeping and client confidentiality

Lecture 40 Awareness of new research

Lecture 41 Risk Mitigation

Section 6: Psilocybin Pharmacology, Neuroscience, and Clinical Research

Lecture 42 Intro to Psilocybin Pharmacology Video

Lecture 43 Campton's Conceptualization: Neurogenesis

Lecture 44 Pharmacodynamics and pharmacokinetics of psilocybin

Lecture 45 Metabolism of Psilocybin

Lecture 46 Drug and supplement interaction

Lecture 47 Effects on brain and neurotransmitter systems

Lecture 48 The Neuroscience of Psilocybin

Lecture 49 Key areas of psilocybin research

Lecture 50 Models of substance use, addiction, and recovery

Lecture 51 Chemical Properties

Lecture 52 Physiological effects

Lecture 53 Risk reduction strategies

Lecture 54 Legal and regulatory issues

Section 7: Psychological Effects of Psilocybin

Lecture 55 Introduction to the Psychological Effects of Psilocybin

Lecture 56 Subjective experiences and effects of psilocybin

Lecture 57 Models of the mind and self

Lecture 58 Spiritual and mystical experiences

Lecture 59 Emotional processing and therapeutic potential

Lecture 60 The Psychedelic Experience

Section 8: Core Facilitation Skills

Lecture 61 Intro to Core Facilitation Skills Video

Lecture 62 Building Rapport

Lecture 63 Setting Intentions

Lecture 64 Risk and Benefit Assessment

Lecture 65 Confidentiality

Lecture 66 Intro to Difficult Experiences Video

Lecture 67 Managing Difficult experiences

Lecture 68 Boundaries for Facilitators

Lecture 69 Intro to Set and Setting Video

Lecture 70 Set and Setting

Lecture 71 Client communication

Lecture 72 Physical reactions and side effects of psilocybin

Lecture 73 Addressing Adverse Reactions

Lecture 74 Trauma informed care

Lecture 75 Uniqueness of Terminal Illness

Lecture 76 Legal and ethical professionalism

Section 9: Preparation and Orientation

Lecture 77 Intro to Preparation Video

Lecture 78 The Preparation Process

Lecture 79 Preparation

Lecture 80 Informed Consent

Lecture 81 Oregon Informed Consent

Lecture 82 Client Intake & Interview

Lecture 83 Interpreters & Client Support Persons

Lecture 84 Transportation Plans

Lecture 85 Referral to specialized treatment services

Lecture 86 Role of the facilitator in supporting the client

Lecture 87 Scope of Practice

Lecture 88 Trauma informed communication

Lecture 89 Identification of client safety concerns

Lecture 90 Strategies to discuss client safety concerns

Lecture 91 Determination

Lecture 92 Safety Planning

Lecture 93 Boundaries

Lecture 94 Racial and cultural dynamics

Lecture 95 Historical and indigenous modalities of preparation

Section 10: Administration

Lecture 96 Intro to Administration Sessions Video

Lecture 97 Administration Sessions

Lecture 98 Set and Setting

Lecture 99 Dosing Strategies and Considerations

Lecture 100 Experiences on differing dosages

Lecture 101 Physiological considerations

Lecture 102 Delivery mechanisms

Lecture 103 Secondary Doses

Lecture 104 Challenging Behaviors

Lecture 105 Unexpected client disclosures

Lecture 106 Substance-induced psychosis

Lecture 107 Suicidality

Lecture 108 Manifestation of Traumatic Stress

Lecture 109 Trauma’s relationship to the body

Lecture 110 Repressed trauma

Lecture 111 Traumatic stress from systemic oppression

Lecture 112 Safety for trauma resolution

Lecture 113 Facilitator Safety Protocols

Lecture 114 Psilocybin Journey Experience Narrative 1

Lecture 115 Psilocybin Journey Experience Narrative 2

Lecture 116 Psilocybin Journey Experience Narrative 3

Lecture 117 Psilocybin Journey Experience Narrative 4

Lecture 118 Psilocybin Journey Experience Narrative 5

Lecture 119 Psilocybin Journey Experience Narrative 6

Lecture 120 Psilocybin Journey Experience Narrative 7

Lecture 121 Psilocybin Journey Experience Narrative 8

Section 11: Integration

Lecture 122 Intro to Integration Sessions Video

Lecture 123 Integration and post-session experiences

Lecture 124 Interpreting feelings and emotions

Lecture 125 Facilitation of positive changes

Lecture 126 Enhancement of existing supportive relationships

Lecture 127 Identification of client safety concerns

Lecture 128 Integration in Clinical Settings

Lecture 129 Facilitator scope of practice

Section 12: Group Facilitation

Lecture 130 Intro to Group Facilitation Video

Lecture 131 Group Preparation Sessions

Lecture 132 Assessing client’s compatibility

Lecture 133 Set and setting for groups

Lecture 134 Group agreements

Lecture 135 Group Administration Sessions

Lecture 136 Facilitating group dynamics

Lecture 137 Identifying when removal is needed

Lecture 138 Group Integration Sessions

Lecture 139 Regulatory requirements for group facilitation

Section 13: Next Steps

Lecture 140 Self-Care and Burnout Prevention

Lecture 141 Residency & Continuing Education

Lecture 142 Residency Video

Lecture 143 Supervision

Section 14: FINAL

This comprehensive curriculum is designed to provide in-depth education and training for licensed professionals seeking to become competent and responsible psilocybin facilitators.,This course for licensed healthcare and mental health workers who are interested in learning about psilocybin and its potential therapeutic applications. It aims to provide participants with a comprehensive understanding of psilocybin, including its history, pharmacology, therapeutic uses, and legal status.,This course is designed to meet the requirements for psilocybin facilitators to be licensed in the state of Oregon, in accordance with the regulations outlined in ORS chapter 475A